Q1 2013 13F Holders as of 3/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
130M
-
Number of holders
-
2
-
Total shares
-
210K
-
Shares change
-
-120
-
Total reported value, excl. options
-
$5.12M
-
Value change
-
-$2.19K
-
Number of sells
-
-1
-
Price
-
$24.35
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q1 2013
2 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock as of Q1 2013.
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 210K shares
of 130M outstanding shares and own 0.16% of the company stock.
Largest 3 shareholders include NORGES BANK (207K shares), HUNTINGTON NATIONAL BANK (3K shares), and Smith Affiliated Capital Corp. (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.